AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + AN2690 Solution Vehicle
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Distal, Subungual Onychomycosis
Conditions
Distal, Subungual Onychomycosis
Trial Timeline
Feb 28, 2006 → Jul 31, 2007
NCT ID
NCT00679965About AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + AN2690 Solution Vehicle
AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + AN2690 Solution Vehicle is a phase 2 stage product being developed by Pfizer for Distal, Subungual Onychomycosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00679965. Target conditions include Distal, Subungual Onychomycosis.
What happened to similar drugs?
0 of 1 similar drugs in Distal, Subungual Onychomycosis were approved
Approved (0) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00679965 | Phase 2 | Completed |
Competing Products
2 competing products in Distal, Subungual Onychomycosis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + Vehicle | Pfizer | Phase 2 | 35 |
| ADV7103 + Placebo | Advicenne | Phase 3 | 22 |